Cole Eye Institute Retina Summit
Saturday, May 1, 2021
Tune In Virtually
Join Us
The annual Cole Eye Institute Retina Summit will take place Saturday, May 1, 2021 prior to the virtual ARVO Annual Meeting.
The virtual summit will include didactic presentations and discussions focused on recent clinical study results and their application to clinical practice. The program will have interactive case-based sessions, with a dedicated audience question-and-answer session.
Course Objectives
At the conclusion of this activity, participants will be able to:
- Diagnosis retinal diseases and assess treatment response using new and emerging imaging modalities
- Assess clinical evidence supporting approved therapeutics for retinal diseases
- Understand the role of biosimilar drugs in clinical practice
- Recognize the emerging role of port delivery systems
- Prepare for the entry of bispecific molecules and other emerging therapies for neovascular AMD and diabetic macular edema
- Detail how complement inhibitors may slow the growth of geographic atrophy
- Optimize retinal surgical outcomes through appropriate patient selection and use of retinal surgical systems
Target Audience
The Cole Eye Institute Retina Summit is for retina specialists, comprehensive ophthalmologists, retina fellows, and healthcare providers who are interested in applying the most recent advancements in retina.
Faculty
Peter K. Kaiser, MD
Educational Course Director
Cole Eye Institute, Cleveland Clinic
Cleveland, OH
Rishi P. Singh, MD
Educational Course Director
Cole Eye Institute, Cleveland Clinic
Cleveland, OH
Sunil K. Srivastava, MD
Educational Course Director
Cole Eye Institute, Cleveland Clinic
Cleveland, OH
Caroline R. Baumal, MD
Tufts Medical Center
Boston, MA
Arshad Khanani, MD, MA
Sierra Eye Associates
Reno, NV
Jaclyn L. Kovach, MD
University of Miami Health System
Naples, FL
Katherine Talcott, MD
Cole Eye Institute, Cleveland Clinic
Cleveland, OH
Alex Yuan, MD, PhD
Cole Eye Institute, Cleveland Clinic
Cleveland, OH
Accreditation Information
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and iVista Medical Education, Inc. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or danger in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Disclosure of Unlabeled Use
This educational activity may contain discussion or published and /or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the education activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Credit Designation Statement
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
